Follow
Partner with Us
Should you go for pharma funds amid fresh spike in covid cases?
Should you go for pharma funds amid fresh spike in covid cases?
00:00 / 00:00

Available Episodes

EPISODE 720

Mint's Sashind talks to Karan Dutta, former chief business officer of Axis Mutual Fund regarding how he retired at the age of 48. Read more

Mint's Sashind talks to Karan Dutta, former chief business officer of Axis Mutual Fund regarding how he retired at the age of 48. Read more

EPISODE 719

Mint's Akshat talks to Trivesh D, COO at Tradejini about the various challenges and lack of awareness among the retail investors regarding the portbaility of demat accounts. Read more

Mint's Akshat talks to Trivesh D, COO at Tradejini about the various challenges and lack of awareness among the retail investors regarding the portbaility of demat accounts. Read more

EPISODE 718

Rising interest rates have led to 20-year home loan tenures of borrowers, rising up to 40 years. RBI has now come with a new rule, where banks need to give both existing and new ho ... Read more

Rising interest rates have led to 20-year home loan tenures of borrowers, rising up to 40 years. RBI has now come with a new rule, where banks need to give both existing and new home loan borrowers the option to choose fixed interest rate. The new rule is effective from 31 December 2023 in today's episode, we chat with Harshad Chetanwala, co-founder of MyWealthGrowth.com on whether borrowers should move from floating rate to fixed rate or stick with the former. Read more

EPISODE 717

Mint's Sashind speaks to Nirav Karkera, head of research at Fisdom about quant-based mutual funds in India and if investors should include them in their portfolios. Read more

Mint's Sashind speaks to Nirav Karkera, head of research at Fisdom about quant-based mutual funds in India and if investors should include them in their portfolios. Read more

EPISODE 716

Mint's Shipra speaks to Nishant Batra, Holistic Prime Wealth and a MF distributor about RBI's recent guidelines issued to banks on mitigating the shock of interest rates on home lo ... Read more

Mint's Shipra speaks to Nishant Batra, Holistic Prime Wealth and a MF distributor about RBI's recent guidelines issued to banks on mitigating the shock of interest rates on home loan borrowers Read more

EPISODE 715

In this episode of Why Not Mint Money, we explore the benefits of taking a loan against your mutual funds, discussing tax efficiency, compound growth, and market timing advantages. ... Read more

In this episode of Why Not Mint Money, we explore the benefits of taking a loan against your mutual funds, discussing tax efficiency, compound growth, and market timing advantages. Discover why this alternative could be a wiser choice for your financial goals." Read more

EPISODE 714

While there is growing awareness on estate planning in India, only a few of them do it with proper legal care. In today's episode of Why Not Mint Money, we chat with Tejal Gandhi, ... Read more

While there is growing awareness on estate planning in India, only a few of them do it with proper legal care. In today's episode of Why Not Mint Money, we chat with Tejal Gandhi, who is a certified financial planner, on the various nitty-gritty when it comes to estate planning. Read more

EPISODE 713

Mint's Sashind Ningthoukhongjam invites Kalpen Parekh, CEO of DSP Mutual Fund to talk about multi-asset allocation funds Read more

Mint's Sashind Ningthoukhongjam invites Kalpen Parekh, CEO of DSP Mutual Fund to talk about multi-asset allocation funds Read more

EPISODE 712

Mint's Shipra tells you what to expect from the lifetime free metallic credit card, OneCard Read more

Mint's Shipra tells you what to expect from the lifetime free metallic credit card, OneCard Read more

EPISODE 711

Join us on this episode of Why Not Mint Money as we unravel the world of unlisted companies and their allure to retail shareholders. From the Reliance Retail squeeze-out saga to th ... Read more

Join us on this episode of Why Not Mint Money as we unravel the world of unlisted companies and their allure to retail shareholders. From the Reliance Retail squeeze-out saga to the rollercoaster journeys of Ricoh and PharmEasy, we dissect real cases that shed light on the challenges of investing in unlisted shares. Read more

1 14 15 16 17 18 87
×

COOKIES AND PRIVACY

The Website uses cookies to ensure you get the best experience on our website. If you continue browsing you will be providing your consent to our use of these.

Privacy Policy